Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
- PMID: 29034071
- PMCID: PMC5629766
- DOI: 10.1186/s13578-017-0179-x
Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
Abstract
Apigenin is a common dietary flavonoid that is abundantly present in many fruits, vegetables and Chinese medicinal herbs and serves multiple physiological functions, such as strong anti-inflammatory, antioxidant, antibacterial and antiviral activities and blood pressure reduction. Therefore, apigenin has been used as a traditional medicine for centuries. Recently, apigenin has been widely investigated for its anti-cancer activities and low toxicity. Apigenin was reported to suppress various human cancers in vitro and in vivo by multiple biological effects, such as triggering cell apoptosis and autophagy, inducing cell cycle arrest, suppressing cell migration and invasion, and stimulating an immune response. In this review, we focus on the most recent advances in the anti-cancer effects of apigenin and their underlying mechanisms, and we summarize the signaling pathways modulated by apigenin, including the PI3K/AKT, MAPK/ERK, JAK/STAT, NF-κB and Wnt/β-catenin pathways. We also discuss combinatorial strategies to enhance the anti-cancer effect of apigenin on various cancers and its use as an adjuvant chemotherapeutic agent to overcome cancer drug resistance or to alleviate other adverse effects of chemotherapy. The functions of apigenin against cancer stem cells are also summarized and discussed. These data demonstrate that apigenin is a promising reagent for cancer therapy. Apigenin appears to have the potential to be developed either as a dietary supplement or as an adjuvant chemotherapeutic agent for cancer therapy.
Keywords: Anti-cancer; Apigenin; Combination therapy; Mechanism of action.
Figures
Similar articles
-
A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanisms.Food Sci Nutr. 2023 Aug 28;11(11):6789-6801. doi: 10.1002/fsn3.3645. eCollection 2023 Nov. Food Sci Nutr. 2023. PMID: 37970406 Free PMC article. Review.
-
Insights into Pharmacological Potential of Apigenin through Various Pathways on a Nanoplatform in Multitude of Diseases.Curr Pharm Des. 2023;29(17):1326-1340. doi: 10.2174/1381612829666230529164321. Curr Pharm Des. 2023. PMID: 37254541 Review.
-
Resources for Human Health from the Plant Kingdom: The Potential Role of the Flavonoid Apigenin in Cancer Counteraction.Int J Mol Sci. 2023 Dec 23;25(1):251. doi: 10.3390/ijms25010251. Int J Mol Sci. 2023. PMID: 38203418 Free PMC article. Review.
-
Apigenin: A dietary flavonoid with diverse anticancer properties.Cancer Lett. 2018 Jan 28;413:11-22. doi: 10.1016/j.canlet.2017.10.041. Epub 2017 Oct 31. Cancer Lett. 2018. PMID: 29097249 Review.
-
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.Biomed Pharmacother. 2018 Jul;103:699-707. doi: 10.1016/j.biopha.2018.04.072. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29680738
Cited by
-
Exploring the recent trends in perturbing the cellular signaling pathways in cancer by natural products.Front Pharmacol. 2022 Sep 8;13:950109. doi: 10.3389/fphar.2022.950109. eCollection 2022. Front Pharmacol. 2022. PMID: 36160435 Free PMC article. Review.
-
The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model.Elife. 2020 Jul 28;9:e56235. doi: 10.7554/eLife.56235. Elife. 2020. PMID: 32720645 Free PMC article.
-
The Effect of Encapsulated Apigenin Nanoparticles on HePG-2 Cells through Regulation of P53.Pharmaceutics. 2022 May 29;14(6):1160. doi: 10.3390/pharmaceutics14061160. Pharmaceutics. 2022. PMID: 35745733 Free PMC article.
-
Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.Molecules. 2022 Jul 4;27(13):4304. doi: 10.3390/molecules27134304. Molecules. 2022. PMID: 35807549 Free PMC article. Review.
-
In Vitro Antibacterial and Antiproliferative Potential of Echinops lanceolatus Mattf. (Asteraceae) and Identification of Potential Bioactive Compounds.Pharmaceuticals (Basel). 2020 Mar 30;13(4):59. doi: 10.3390/ph13040059. Pharmaceuticals (Basel). 2020. PMID: 32235626 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
